ALLMedicine™ Robotic Surgery Center

Dec 2nd, 2021 - We assessed locoregional control with omission of intentional primary site radiation after transoral robotic surgery (TORS) and quantified nontargeted primary site dose. Following Institutional Review Board (IRB) approval, patients treated with pr...

Nov 17th, 2021 - The primary course of treatment for patients with low- to intermediate-risk tonsil cancer has evolved with a shift toward primary transoral robotic surgery (TORS) or radiation therapy (RT). While favorable outcomes have been reported after deinten...

Nov 12th, 2021 - Transoral robotic surgery (TORS) was approved by the Food and Drug Administration in 2009 for the treatment of oropharyngeal cancers (oropharyngeal squamous cell carcinoma [OPSCC]). This study investigated the adoption and safety of TORS. All pati...

Nov 11th, 2021 - Dr. Claude Organ rose above poverty, racism, and untold insurmountable odds to become a masterful surgeon and revered leader in numerous academic and professional circles. But it's his impact on surgical education and his philosophy to "teach, giv...

Nov 10th, 2021 - To evaluate 2-year follow-up swallowing function in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma (HPV+ OPSCC) who completed neoadjuvant chemotherapy and transoral robotic surgery (NAC+S). Retrospective analysis ...

Oct 29th, 2021 - NEW YORK (Reuters Health) - Among carefully selected patients with HPV-positive oropharynx squamous cell carcinoma (OPSCC) undergoing primary transoral robotic surgery (TORS), it is likely that 25% will need radiochemotherapy afterward, a single-c...

Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...

Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...

Aug 24th, 2020 - Transoral robotic surgery (TORS) was associated with better survival and improved surgical outcomes in comparison with nonrobotic surgery in patients with early-stage oropharyngeal cancer in a retrospective analysis of nearly 10,000 cases. The sur...

Jun 12th, 2019 - CHICAGO — For patients with oropharyngeal squamous cell cancer (OPSCC), opting for radiation therapy rather than surgery may result in better swallowing outcomes, which in turn may mean a better quality of life, according to new findings. The find...